Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies

Figure 1

The overview of phenotypes and proliferation rate of enhanced CIK cells and conventional CIK cells. (a) The representative data of flow cytometry. (b) The histogram showed quantified results of CD3⁺, CD3⁺CD4⁺, CD3⁺CD8⁺, and CD3⁺CD56⁺ cells in cultured enhanced CIK cells, conventional CIK cells, and PBMC and expressed as the percentage in lymphocytes. (c) The proliferation rate of enhanced CIK cells and conventional CIK cells. Difference between enhanced CIK cells and controls was determined by Student’s t-test. , and n = 10.

(a)

(b)

(c)